EXoPERT EMERALD: Early Multi-cancer Study of EV's Ramen-AL Linked Diagnosis Clinical Study Protocol
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
Invitro diagnostic test for multiple cancer diagnosis for patients with early-stage cancers by analyzing surface-enhanced Ramen spectroscopy (SERS) profiles of extracellular vesicles (EV) using artificial intelligence.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Healthy Volunteers: t
View:
• Subjects aged 45 years or older with a biopsy-proven lung, breast, colorectal, pancreatic, or ovarian cancer, as their primary cancer, but whose blood was collected prior to any systemic or definitive therapy for the cancer.
• Subjects who are willing and able to provide written informed consent.
• Subjects who are willing and able to comply with the study requirements.
Locations
United States
Kentucky
KCTL
RECRUITING
Louisville
Maryland
John Hopkins University
ACTIVE_NOT_RECRUITING
Baltimore
Contact Information
Primary
Young Park
paark76@korea.ac.kr
(+82) 02 923 8833
Backup
Yeonho Choi
yeonhochoi@exopert.com
(+82) 02 923 8833
Time Frame
Start Date: 2025-05-09
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 1400
Treatments
Control
Lung Cancer
Breast Cancer
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Related Therapeutic Areas
Sponsors
Leads: EXoPERT
Collaborators: MCRA